Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party - PubMed

Affiliations

• PMID: 21596847
• DOI: 10.1182/blood-2011-02-336156

Free article

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

Thomas Daikeler et al. Blood. 2011.

Free article

Abstract

To specify the incidence and risk factors for secondary autoimmune diseases (ADs) after HSCT for a primary AD, we retrospectively analyzed AD patients treated by HSCT reported to EBMT from 1995 to 2009 with at least 1 secondary AD (cases) and those without (controls). After autologous HSCT, 29 of 347 patients developed at least 1 secondary AD within 21.9 (0.6-49) months and after allogeneic HSCT, 3 of 16 patients. The observed secondary ADs included: autoimmune hemolytic anemia (n = 3), acquired hemophilia (n = 3), autoimmune thrombocytopenia (n = 3), antiphospholipid syndrome (n = 2), thyroiditis (n = 12), blocking thyroid-stimulating hormone receptor antibody (n = 1), Graves disease (n = 2), myasthenia gravis (n = 1), rheumatoid arthritis (n = 2), sarcoidosis (n = 2), vasculitis (n = 1), psoriasis (n = 1), and psoriatic arthritis (n = 1). After autologous HSCT for primary AD, the cumulative incidence of secondary AD was 9.8% ± 2% at 5 years. Lupus erythematosus as primary AD, and antithymocyte globulin use plus CD34(+) graft selection were important risk factors for secondary AD by multivariate analysis. With a median follow-up of 6.2 (0.54-11) years after autologous HSCT, 26 of 29 patients with secondary AD were alive, 2 died during their secondary AD (antiphospholipid syndrome, hemophilia), and 1 death was HSCT-related. This European multicenter study underlines the need for careful management and follow-up for secondary AD after HSCT.

Comment in

• HSCT for AID: entering prime time?

  Pavletic SZ. Pavletic SZ. Blood. 2011 Aug 11;118(6):1438-9. doi: 10.1182/blood-2011-06-356576. Blood. 2011. PMID: 21835965 No abstract available.

Similar articles

• New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation.

  Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA, Carlson K, Cornillon J, Diez-Martin JL, Gandemer V, Faraci M, Lindemans C, O'Meara A, Mialou V, Renard M, Sedlacek P, Sirvent A, Socié G, Sora F, Varotto S, Sanz J, Voswinkel J, Vora A, Yesilipek MA, Herr AL, Gluckman E, Farge D, Rocha V. Daikeler T, et al. Blood. 2013 Feb 7;121(6):1059-64. doi: 10.1182/blood-2012-07-445965. Epub 2012 Dec 17. Blood. 2013. PMID: 23247725

• Long-term follow-up of fertility and pregnancy in autoimmune diseases after autologous haematopoietic stem cell transplantation.

  Massenkeil G, Alexander T, Rosen O, Dörken B, Burmester G, Radbruch A, Hiepe F, Arnold R. Massenkeil G, et al. Rheumatol Int. 2016 Nov;36(11):1563-1568. doi: 10.1007/s00296-016-3531-2. Epub 2016 Aug 13. Rheumatol Int. 2016. PMID: 27522225

• Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.

  Bryant A, Atkins H, Pringle CE, Allan D, Anstee G, Bence-Bruckler I, Hamelin L, Hodgins M, Hopkins H, Huebsch L, McDiarmid S, Sabloff M, Sheppard D, Tay J, Bredeson C. Bryant A, et al. JAMA Neurol. 2016 Jun 1;73(6):652-8. doi: 10.1001/jamaneurol.2016.0113. JAMA Neurol. 2016. PMID: 27043206

• Autologous stem cell transplantation in autoimmune diseases.

  Passweg J, Tyndall A. Passweg J, et al. Semin Hematol. 2007 Oct;44(4):278-85. doi: 10.1053/j.seminhematol.2007.08.001. Semin Hematol. 2007. PMID: 17961728 Review.

• General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE).

  Jessop H, Farge D, Saccardi R, Alexander T, Rovira M, Sharrack B, Greco R, Wulffraat N, Moore J, Kazmi M, Badoglio M, Adams G, Verhoeven B, Murray J, Snowden JA. Jessop H, et al. Bone Marrow Transplant. 2019 Jul;54(7):933-942. doi: 10.1038/s41409-019-0430-7. Epub 2019 Jan 31. Bone Marrow Transplant. 2019. PMID: 30705338 Free PMC article. Review.

Cited by

• Hematopoietic Cell Transplantation for Systemic Sclerosis-A Review.

  Levin D, Osman MS, Durand C, Kim H, Hemmati I, Jamani K, Howlett JG, Johannson KA, Weatherald J, Woo M, Lee J, Storek J. Levin D, et al. Cells. 2022 Dec 3;11(23):3912. doi: 10.3390/cells11233912. Cells. 2022. PMID: 36497169 Free PMC article. Review.

• Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell Transplant compared with matched sibling and unrelated donor.

  Lv W, Fan Z, Huang F, Xu N, Xuan L, GuopanYu, Jiang Q, Zhou H, Lin R, Zhang X, Sun J, Liu Q. Lv W, et al. Oncotarget. 2017 Apr 18;8(16):26505-26514. doi: 10.18632/oncotarget.15710. Oncotarget. 2017. PMID: 28460445 Free PMC article.

• Hematopoietic stem cell transplantation for systemic lupus erythematosus.

  Marmont du Haut Champ AM. Marmont du Haut Champ AM. Clin Dev Immunol. 2012;2012:380391. doi: 10.1155/2012/380391. Epub 2012 Aug 30. Clin Dev Immunol. 2012. PMID: 22969816 Free PMC article. Review.

• Haemopoietic stem cell transplantation in Systemic lupus erythematosus: a systematic review.

  de Silva NL, Seneviratne SL. de Silva NL, et al. Allergy Asthma Clin Immunol. 2019 Sep 18;15:59. doi: 10.1186/s13223-019-0373-y. eCollection 2019. Allergy Asthma Clin Immunol. 2019. PMID: 31548842 Free PMC article. Review.

• Analysis of seizure risk factors after allogeneic hematopoietic stem cell transplantation: a 8 case report and literature review.

  Zhong ZD, Li L, Wu YH, You Y, Li WM, Zou P. Zhong ZD, et al. J Huazhong Univ Sci Technolog Med Sci. 2013 Oct;33(5):656-660. doi: 10.1007/s11596-013-1176-x. Epub 2013 Oct 20. J Huazhong Univ Sci Technolog Med Sci. 2013. PMID: 24142716 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information